14%AZELAIC ACID

14%AZELAIC ACID was reported 839 times

14%AZELAIC ACID is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 DIAMINE OXIDASE DEFICIENCY 1 0.2500
1 PATHOLOGICAL TOOTH FRACTURE 1 0.1250
2 CARBOHYDRATE TOLERANCE DECREASED 1 0.0455
3 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, MIXED TYPE 1 0.0435
4 HYPOCHOLESTEROLAEMIA 13 0.0368
5 SKIN LESION INFLAMMATION 4 0.0303
6 APPLICATION SITE PALLOR 1 0.0303
7 OSTEOMA CUTIS 1 0.0294
8 PSYCHOLOGICAL FACTOR AFFECTING MEDICAL CONDITION 1 0.0213
9 LACK OF INFUSION SITE ROTATION 1 0.0208
10 PACEMAKER GENERATED RHYTHM 1 0.0189
11 LUPUS VULGARIS 22 0.0175
12 COMPLICATED FRACTURE 1 0.0161
13 BLEPHAROSPASM 95 0.0151
14 ACQUIRED PORPHYRIA 1 0.0141
15 HEPATIC ENZYME 2 0.0134
16 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 7 0.0125
17 CHORIORETINAL SCAR 1 0.0120
18 SWOLLEN JOINT COUNT 3 0.0120
19 TENDER JOINT COUNT 1 0.0119
20 TETHERED ORAL TISSUE 1 0.0119
21 SPECIFIC GRAVITY URINE ABNORMAL 1 0.0118
22 OVERLAP SYNDROME 8 0.0114
23 MIXED INCONTINENCE 1 0.0110
24 PELVIC ORGAN PROLAPSE 1 0.0110
25 POSTOPERATIVE HERNIA 1 0.0109
26 RHEUMATIC FEVER 48 0.0108
27 FACET JOINT SYNDROME 35 0.0107
28 ADMINISTRATION SITE DISCOMFORT 2 0.0106
29 CARDIAC VALVE RUPTURE 1 0.0098
30 SWOLLEN JOINT COUNT INCREASED 31 0.0097
31 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, HYPERSOMNIA TYPE 1 0.0095
32 CAROTID ARTERY ATHEROMA 1 0.0094
33 PERIPHERAL VENOUS DISEASE 38 0.0093
34 RETINITIS 16 0.0093
35 DISLOCATION OF VERTEBRA 21 0.0092
36 X-RAY ABNORMAL 16 0.0089
37 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 18 0.0087
38 C-REACTIVE PROTEIN 8 0.0086
39 DEEP VEIN THROMBOSIS POSTOPERATIVE 17 0.0085
40 IRON METABOLISM DISORDER 1 0.0084
41 BLEPHAROPLASTY 1 0.0082
42 ONYCHOMADESIS 28 0.0067
43 MALABSORPTION FROM APPLICATION SITE 1 0.0065
44 SCAN MYOCARDIAL PERFUSION ABNORMAL 1 0.0065
45 DIASTASIS RECTI ABDOMINIS 1 0.0062
46 LUMBOSACRAL RADICULOPATHY 1 0.0062
47 INFANTILE HAEMANGIOMA 1 0.0062
48 INFUSION SITE REACTION 18 0.0060
49 DOSING ERROR 1 0.0060
50 LABELLED DRUG-FOOD INTERACTION ISSUE 1 0.0059
51 SWELLING OF NOSE 1 0.0058
52 BREAST CANCER STAGE III 37 0.0057
53 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 40 0.0056
54 RICKETS 1 0.0053
55 PRODUCT PHYSICAL CONSISTENCY ISSUE 29 0.0052
56 ROSACEA 23 0.0049
57 OCULAR ROSACEA 1 0.0049
58 PORPHYRIA ACUTE 7 0.0049
59 RHEUMATOID FACTOR POSITIVE 28 0.0048
60 DUODENAL ULCER PERFORATION 36 0.0048
61 PRODUCT ADVERTISING ISSUE 1 0.0047
62 CHOLELITHOTOMY 1 0.0046
63 TASTE DISORDER 93 0.0046
64 MECHANICAL URTICARIA 2 0.0043
65 FOLLICULITIS 44 0.0042
66 LIVE BIRTH 35 0.0042
67 KYPHOSCOLIOSIS 1 0.0038
68 PALMOPLANTAR PUSTULOSIS 2 0.0038
69 CHOLESTEATOMA 1 0.0036
70 PRODUCT INFORMATION CONTENT COMPLAINT 1 0.0036
71 SERONEGATIVE ARTHRITIS 4 0.0035
72 BONE EROSION 12 0.0034
73 ADENOMYOSIS 2 0.0034
74 WOUND INFECTION 36 0.0033
75 BACK INJURY 35 0.0032
76 BURSITIS 39 0.0032
77 CONDUCTIVE DEAFNESS 1 0.0031
78 CELLULITE 1 0.0031
79 BLOOD CREATINE PHOSPHOKINASE DECREASED 1 0.0030
80 PSEUDOCIRRHOSIS 1 0.0030
81 SALIVA DISCOLOURATION 1 0.0030
82 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 2 0.0030
83 SYNOVITIS 54 0.0030
84 RED BLOOD CELL SEDIMENTATION RATE INCREASED 33 0.0030
85 EXOSTOSIS 27 0.0030
86 EPILEPSY 90 0.0029
87 PSEUDOSTROKE 1 0.0029
88 GASTROINTESTINAL MICROORGANISM OVERGROWTH 1 0.0028
89 MULTIPLE SYSTEM ATROPHY 1 0.0028
90 MUSCLE INJURY 23 0.0028
91 GLOBULINS INCREASED 1 0.0027
92 FEEDING TUBE USER 1 0.0027
93 VITAMIN B COMPLEX DEFICIENCY 2 0.0027
94 HYPERCHOLESTEROLAEMIA 26 0.0027
95 C-REACTIVE PROTEIN ABNORMAL 17 0.0026
96 PEMPHIGUS 33 0.0026
97 PERICARDITIS 44 0.0026
98 POLYCYSTIC OVARIAN SYNDROME 1 0.0026
99 PREGNANCY TEST POSITIVE 1 0.0025
100 DRUG TOLERANCE DECREASED 7 0.0025
101 LIP DRY 22 0.0024
102 HELICOBACTER INFECTION 24 0.0023
103 SARCOPENIA 1 0.0023
104 APPLICATION SITE PARAESTHESIA 3 0.0023
105 SKIN LAXITY 1 0.0023
106 PRODUCT WITH QUALITY ISSUE ADMINISTERED 1 0.0022
107 JOINT RANGE OF MOTION DECREASED 30 0.0022
108 STRESS SYMPTOMS 1 0.0022
109 ALLERGY TO ARTHROPOD STING 1 0.0022
110 INJURY ASPHYXIATION 1 0.0022
111 BIOPSY BONE MARROW 1 0.0021
112 MENINGISM 1 0.0021
113 BLOOD CREATINE ABNORMAL 1 0.0021
114 TELANGIECTASIA 2 0.0021
115 PUSTULAR PSORIASIS 7 0.0020
116 ROOT CANAL INFECTION 1 0.0020
117 DERMATITIS INFECTED 1 0.0020
118 HYPERMOBILITY SYNDROME 1 0.0020
119 NAIL DISORDER 17 0.0019
120 INTERVERTEBRAL DISC DISPLACEMENT 1 0.0019
121 PHARYNGEAL MASS 1 0.0019
122 COATING IN MOUTH 1 0.0019
123 HAND DEFORMITY 24 0.0018
124 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 31 0.0018
125 ONYCHOMYCOSIS 8 0.0018
126 MILK ALLERGY 1 0.0018
127 MITRAL VALVE PROLAPSE 3 0.0018
128 MEAN CELL HAEMOGLOBIN CONCENTRATION INCREASED 1 0.0018
129 JUGULAR VEIN DISTENSION 1 0.0018
130 ACUTE SINUSITIS 3 0.0017
131 EUSTACHIAN TUBE DYSFUNCTION 1 0.0017
132 GRIP STRENGTH DECREASED 15 0.0017
133 BREAST CANCER STAGE II 14 0.0017
134 MALE SEXUAL DYSFUNCTION 1 0.0017
135 RASH VESICULAR 8 0.0017
136 ALLERGY TO METALS 1 0.0016
137 CUTANEOUS VASCULITIS 6 0.0016
138 WOUND 45 0.0016
139 DERMATOSIS 1 0.0016
140 PLEURAL DISORDER 1 0.0016
141 BAND SENSATION 2 0.0016
142 PERIORAL DERMATITIS 1 0.0016
143 ACTIVITIES OF DAILY LIVING DECREASED 1 0.0016
144 LUPUS-LIKE SYNDROME 14 0.0015
145 CONTRAINDICATED PRODUCT ADMINISTERED 46 0.0015
146 MAMMOGRAM ABNORMAL 1 0.0015
147 IRRITABLE BOWEL SYNDROME 32 0.0015
148 EYELID PAIN 3 0.0015
149 NORMAL NEWBORN 8 0.0015
150 CALCULUS BLADDER 2 0.0015
151 CONGENITAL HAND MALFORMATION 1 0.0015
152 HEAD TITUBATION 2 0.0015
153 INGROWN HAIR 1 0.0014
154 ARACHNOIDITIS 1 0.0014
155 GLOSSODYNIA 32 0.0014
156 CONGENITAL HYDRONEPHROSIS 1 0.0014
157 CERVIX DISORDER 1 0.0014
158 AMNIOTIC CAVITY INFECTION 1 0.0014
159 GRAFT LOSS 1 0.0014
160 RECALLED PRODUCT ADMINISTERED 13 0.0014
161 FIBROMYALGIA 33 0.0014
162 POOR QUALITY PRODUCT ADMINISTERED 14 0.0013
163 ACNE CYSTIC 4 0.0013
164 CHOLANGITIS ACUTE 1 0.0013
165 EYE INJURY 4 0.0013
166 NIGHT SWEATS 42 0.0013
167 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 3 0.0013
168 JOINT DESTRUCTION 2 0.0013
169 GASTROOESOPHAGEAL REFLUX DISEASE 102 0.0013
170 INTRACRANIAL PRESSURE INCREASED 7 0.0013
171 SYSTEMIC LUPUS ERYTHEMATOSUS RASH 1 0.0013
172 BREAST CALCIFICATIONS 1 0.0013
173 LIP ERYTHEMA 1 0.0013
174 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 8 0.0012
175 GENITAL INFECTION FUNGAL 1 0.0012
176 GIANT CELL ARTERITIS 1 0.0012
177 MEDICAL PROCEDURE 2 0.0012
178 OBESITY 19 0.0012
179 ULCER HAEMORRHAGE 8 0.0012
180 CERVICAL SPINAL STENOSIS 2 0.0012
181 ENDOCRINE OPHTHALMOPATHY 1 0.0012
182 INFUSION SITE DISCOLOURATION 1 0.0011
183 AUTOIMMUNE DISORDER 11 0.0011
184 PAPILLOEDEMA 5 0.0011
185 SPONDYLITIS 4 0.0011
186 C-REACTIVE PROTEIN INCREASED 40 0.0011
187 MIGRAINE 101 0.0011
188 SOLAR LENTIGO 1 0.0011
189 SKIN TEXTURE ABNORMAL 1 0.0010
190 INFUSION SITE NODULE 1 0.0010
191 HYPERTONIC BLADDER 3 0.0010
192 IMPAIRED HEALING 34 0.0010
193 FINGER DEFORMITY 5 0.0010
194 CUTANEOUS LUPUS ERYTHEMATOSUS 2 0.0010
195 GALLBLADDER INJURY 2 0.0010
196 GAIT INABILITY 33 0.0010
197 PSORIATIC ARTHROPATHY 40 0.0010
198 LIGHT CHAIN ANALYSIS INCREASED 1 0.0010
199 INFUSION SITE DISCOMFORT 1 0.0010
200 EYELIDS PRURITUS 3 0.0010
201 TYPE 2 DIABETES MELLITUS 32 0.0009
202 DRUG INTOLERANCE 91 0.0009
203 STRESS URINARY INCONTINENCE 1 0.0009
204 PRESCRIBED OVERDOSE 18 0.0009
205 SYSTEMIC LUPUS ERYTHEMATOSUS 33 0.0009
206 INFUSION SITE MASS 1 0.0009
207 PILOERECTION 1 0.0009
208 AORTIC DILATATION 1 0.0009
209 CATHETER SITE DISCHARGE 1 0.0009
210 GASTROINTESTINAL BACTERIAL INFECTION 1 0.0009
211 EAR PAIN 17 0.0009
212 POLYDACTYLY 1 0.0009
213 INFUSION SITE INFECTION 2 0.0009
214 PRESCRIBED UNDERDOSE 17 0.0009
215 HEPATIC CIRRHOSIS 16 0.0009
216 STOMATITIS 51 0.0008
217 SUBCUTANEOUS ABSCESS 4 0.0008
218 INFLAMMATION 43 0.0008
219 BRONCHIAL HYPERREACTIVITY 1 0.0008
220 OSTEOARTHRITIS 35 0.0008
221 INFUSION SITE WARMTH 1 0.0008
222 BLOOD ELECTROLYTES ABNORMAL 1 0.0008
223 THERAPEUTIC PRODUCT EFFECT DECREASED 36 0.0008
224 RESPIRATORY DISORDER 24 0.0008
225 BENIGN INTRACRANIAL HYPERTENSION 1 0.0008
226 BLOOD CHOLESTEROL INCREASED 37 0.0008
227 BLISTER 44 0.0008
228 SLEEP DISORDER 55 0.0008
229 EPIGASTRIC DISCOMFORT 3 0.0008
230 POSTMENOPAUSAL HAEMORRHAGE 2 0.0008
231 WALKING AID USER 5 0.0008
232 ACROCHORDON 1 0.0008
233 INTERCEPTED PRODUCT PRESCRIBING ERROR 1 0.0008
234 SCIATICA 12 0.0008
235 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 1 0.0007
236 SPINAL FUSION SURGERY 3 0.0007
237 LIP BLISTER 2 0.0007
238 LIVER INJURY 18 0.0007
239 LOWER LIMB FRACTURE 14 0.0007
240 NASAL DISCHARGE DISCOLOURATION 1 0.0007
241 MEMORY IMPAIRMENT 99 0.0007
242 INCISIONAL HERNIA 1 0.0007
243 CHRONIC FATIGUE SYNDROME 1 0.0007
244 THERAPEUTIC PROCEDURE 1 0.0007
245 HALLUCINATIONS, MIXED 3 0.0007
246 GLOMERULAR FILTRATION RATE ABNORMAL 1 0.0007
247 CONNECTIVE TISSUE DISORDER 1 0.0007
248 HAEMORRHAGE IN PREGNANCY 1 0.0007
249 EYELID MARGIN CRUSTING 2 0.0007
250 PRODUCT LABEL CONFUSION 4 0.0007
251 INFUSION SITE INDURATION 1 0.0007
252 GENERAL SYMPTOM 5 0.0007
253 MATERNAL EXPOSURE DURING PREGNANCY 59 0.0007
254 MYOCLONIC EPILEPSY 1 0.0007
255 AGE-RELATED MACULAR DEGENERATION 1 0.0007
256 DERMATITIS ACNEIFORM 4 0.0007
257 HYPOAESTHESIA 98 0.0007
258 RUBBER SENSITIVITY 1 0.0007
259 LIVER FUNCTION TEST INCREASED 14 0.0007
260 PREMATURE SEPARATION OF PLACENTA 1 0.0006
261 PORTAL HYPERTENSION 2 0.0006
262 PARAESTHESIA 102 0.0006
263 POLYCYSTIC OVARIES 1 0.0006
264 BACTERIAL VAGINOSIS 1 0.0006
265 PRODUCT ADMINISTRATION INTERRUPTED 5 0.0006
266 GESTATIONAL DIABETES 3 0.0006
267 FREQUENT BOWEL MOVEMENTS 17 0.0006
268 PULMONARY FIBROSIS 12 0.0006
269 COSTOCHONDRITIS 1 0.0006
270 ARTHROPATHY 34 0.0006
271 APPLICATION SITE BURN 3 0.0006
272 INFUSION SITE HAEMORRHAGE 2 0.0006
273 WHEEZING 36 0.0006
274 INTERCEPTED PRODUCT DISPENSING ERROR 1 0.0006
275 DRUG TOLERANCE 3 0.0006
276 DRY MOUTH 48 0.0006
277 PRODUCT CONTAINER ISSUE 5 0.0006
278 TACHYPHRENIA 2 0.0006
279 PRODUCT CONTAINER SEAL ISSUE 1 0.0006
280 SPLENIC INFARCTION 1 0.0006
281 LUNG DISORDER 28 0.0006
282 SKIN HYPOPIGMENTATION 1 0.0006
283 TERMINAL INSOMNIA 1 0.0006
284 MACULOPATHY 2 0.0006
285 SKIN WEEPING 2 0.0006
286 MYOSITIS 5 0.0006
287 APPLICATION SITE DISCOMFORT 1 0.0006
288 DEVICE ALARM ISSUE 1 0.0006
289 SUSPECTED PRODUCT QUALITY ISSUE 1 0.0005
290 SINUS NODE DYSFUNCTION 1 0.0005
291 NECK PAIN 30 0.0005
292 ABDOMINAL PAIN UPPER 110 0.0005
293 NASAL OBSTRUCTION 1 0.0005
294 MATERNAL EXPOSURE TIMING UNSPECIFIED 2 0.0005
295 PERIORBITAL SWELLING 3 0.0005
296 SACROILIITIS 1 0.0005
297 LIP DISORDER 1 0.0005
298 HEPATIC MASS 1 0.0005
299 CONGENITAL ANOMALY 4 0.0005
300 EARLY SATIETY 1 0.0005
301 SWELLING 48 0.0005
302 ADRENOCORTICAL INSUFFICIENCY ACUTE 1 0.0005
303 OCCULT BLOOD POSITIVE 1 0.0005
304 ALLERGIC REACTION TO EXCIPIENT 1 0.0005
305 ANORECTAL DISORDER 1 0.0005
306 APPLICATION SITE PAIN 11 0.0005
307 HEPATIC ENZYME INCREASED 34 0.0005
308 MUSCULOSKELETAL PAIN 26 0.0005
309 JOINT STIFFNESS 13 0.0005
310 TREATMENT FAILURE 41 0.0005
311 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 35 0.0005
312 DELIRIUM 17 0.0005
313 INFUSION RELATED REACTION 32 0.0005
314 HYPOSPADIAS 1 0.0005
315 LIVEDO RETICULARIS 1 0.0005
316 RHEUMATOID ARTHRITIS 54 0.0005
317 JOINT DISLOCATION 5 0.0005
318 ESCHERICHIA URINARY TRACT INFECTION 2 0.0005
319 SHOULDER OPERATION 2 0.0005
320 CATHETER SITE ERYTHEMA 1 0.0005
321 DEREALISATION 1 0.0005
322 BLOOD MAGNESIUM DECREASED 4 0.0005
323 OSTEOPOROSIS 19 0.0005
324 GASTRIC BYPASS 1 0.0005
325 CERVICAL DYSPLASIA 1 0.0005
326 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 1 0.0005
327 ENDOMETRIAL CANCER 1 0.0005
328 MIDDLE EAR EFFUSION 1 0.0005
329 FOOT DEFORMITY 5 0.0005
330 IDIOPATHIC INTRACRANIAL HYPERTENSION 1 0.0004
331 INJURY 31 0.0004
332 LOWER RESPIRATORY TRACT INFECTION 20 0.0004
333 MATERNAL EXPOSURE BEFORE PREGNANCY 3 0.0004
334 BRAIN OPERATION 1 0.0004
335 AUTOIMMUNE HEPATITIS 3 0.0004
336 SINUS PAIN 1 0.0004
337 SKIN ABRASION 2 0.0004
338 PUSTULE 1 0.0004
339 PRODUCT USE IN UNAPPROVED INDICATION 103 0.0004
340 SKIN IRRITATION 19 0.0004
341 HAEMATOLOGICAL INFECTION 1 0.0004
342 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 7 0.0004
343 COELIAC DISEASE 4 0.0004
344 SENSITIVE SKIN 3 0.0004
345 GASTROINTESTINAL TUBE INSERTION 1 0.0004
346 CHEMICAL BURN OF SKIN 1 0.0004
347 ENDODONTIC PROCEDURE 1 0.0004
348 DISCOMFORT 24 0.0004
349 INSURANCE ISSUE 6 0.0004
350 ABNORMAL UTERINE BLEEDING 1 0.0004
351 GENERAL PHYSICAL HEALTH DETERIORATION 45 0.0004
352 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 3 0.0004
353 CATHETER SITE PAIN 1 0.0004
354 BASAL CELL CARCINOMA 6 0.0004
355 PRODUCT QUALITY ISSUE 52 0.0004
356 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 1 0.0004
357 MYCOBACTERIUM AVIUM COMPLEX INFECTION 1 0.0004
358 ANAESTHETIC COMPLICATION 1 0.0004
359 PRODUCT RESIDUE PRESENT 2 0.0004
360 BLOOD SODIUM INCREASED 1 0.0004
361 CHONDROPATHY 1 0.0004
362 PRODUCT PRESCRIBING ISSUE 8 0.0004
363 UPPER-AIRWAY COUGH SYNDROME 3 0.0004
364 HEART RATE ABNORMAL 2 0.0004
365 PRODUCT LEAKAGE 2 0.0004
366 SWELLING FACE 23 0.0004
367 OESOPHAGEAL STENOSIS 1 0.0004
368 BILIARY COLIC 1 0.0003
369 SKIN WARM 2 0.0003
370 LUMBAR SPINAL STENOSIS 1 0.0003
371 GLUCOSE TOLERANCE IMPAIRED 2 0.0003
372 SINUS HEADACHE 2 0.0003
373 ADRENAL INSUFFICIENCY 4 0.0003
374 HIP ARTHROPLASTY 5 0.0003
375 EXPOSURE DURING PREGNANCY 20 0.0003
376 SWELLING OF EYELID 2 0.0003
377 INFUSION SITE PRURITUS 1 0.0003
378 ELECTROENCEPHALOGRAM ABNORMAL 1 0.0003
379 BLADDER PAIN 1 0.0003
380 POLYMYALGIA RHEUMATICA 1 0.0003
381 ILL-DEFINED DISORDER 19 0.0003
382 THERAPY NON-RESPONDER 14 0.0003
383 PRODUCT USE ISSUE 58 0.0003
384 INTENTIONAL PRODUCT USE ISSUE 27 0.0003
385 BACK DISORDER 5 0.0003
386 AMNESIA 20 0.0003
387 LYMPHOCYTE COUNT INCREASED 1 0.0003
388 SOMNAMBULISM 2 0.0003
389 DEAFNESS NEUROSENSORY 1 0.0003
390 OTITIS MEDIA 1 0.0003
391 PEPTIC ULCER 1 0.0003
392 GASTROINTESTINAL DISORDER 27 0.0003
393 JOINT SWELLING 36 0.0003
394 APPLICATION SITE DRYNESS 1 0.0003
395 MOBILITY DECREASED 21 0.0003
396 ECCHYMOSIS 2 0.0003
397 HYPERTRANSAMINASAEMIA 2 0.0003
398 URTICARIA 48 0.0003
399 CAROTID ARTERY STENOSIS 1 0.0003
400 PERIPHERAL SWELLING 44 0.0003
401 THERMAL BURN 2 0.0003
402 MUSCULAR WEAKNESS 32 0.0003
403 SKIN BURNING SENSATION 20 0.0003
404 FEELING HOT 17 0.0003
405 OEDEMA 15 0.0003
406 ASPIRATION 3 0.0003
407 FOOD INTOLERANCE 1 0.0003
408 IMMUNE-MEDIATED ENTEROCOLITIS 1 0.0003
409 DRUG EFFECT LESS THAN EXPECTED 4 0.0003
410 ARTHROPOD BITE 2 0.0003
411 RETINOPATHY 1 0.0003
412 CHRONIC SINUSITIS 1 0.0003
413 CONFUSIONAL STATE 43 0.0003
414 APHASIA 8 0.0003
415 AUTOIMMUNE THYROIDITIS 1 0.0003
416 SNORING 1 0.0003
417 DERMATITIS CONTACT 3 0.0003
418 ROAD TRAFFIC ACCIDENT 11 0.0003
419 ABDOMINAL DISCOMFORT 44 0.0003
420 PROCEDURAL COMPLICATION 2 0.0003
421 CONTUSION 25 0.0003
422 FOOD ALLERGY 2 0.0003
423 CONCUSSION 2 0.0003
424 PANIC DISORDER 1 0.0003
425 THERAPEUTIC PRODUCT EFFECT VARIABLE 1 0.0003
426 SENSATION OF HEAVINESS 1 0.0003
427 SPLENOMEGALY 3 0.0003
428 DRUG-INDUCED LIVER INJURY 8 0.0003
429 DISABILITY 5 0.0003
430 SKIN PAPILLOMA 1 0.0002
431 BLEPHARITIS 1 0.0002
432 ENURESIS 1 0.0002
433 MATERNAL EXPOSURE DURING BREAST FEEDING 1 0.0002
434 RECURRENT CANCER 1 0.0002
435 ADVERSE DRUG REACTION 22 0.0002
436 GENERALISED OEDEMA 3 0.0002
437 MENSTRUAL DISORDER 2 0.0002
438 WEIGHT INCREASED 54 0.0002
439 ATTENTION DEFICIT HYPERACTIVITY DISORDER 1 0.0002
440 KNEE ARTHROPLASTY 5 0.0002
441 INFUSION SITE ERYTHEMA 2 0.0002
442 LABORATORY TEST ABNORMAL 7 0.0002
443 SKIN PLAQUE 2 0.0002
444 ABSCESS LIMB 1 0.0002
445 WHITE BLOOD CELL COUNT INCREASED 9 0.0002
446 HEPATIC PAIN 1 0.0002
447 INTERVERTEBRAL DISC DISORDER 1 0.0002
448 PURULENT DISCHARGE 1 0.0002
449 VOMITING 110 0.0002
450 DEPRESSION 53 0.0002
451 INFUSION SITE PAIN 3 0.0002
452 SKIN HYPERPIGMENTATION 2 0.0002
453 HYSTERECTOMY 2 0.0002
454 INCORRECT PRODUCT ADMINISTRATION DURATION 5 0.0002
455 CHAPPED LIPS 1 0.0002
456 MELANOCYTIC NAEVUS 1 0.0002
457 BLOOD CALCIUM INCREASED 2 0.0002
458 ORAL CANDIDIASIS 3 0.0002
459 SPINAL OSTEOARTHRITIS 2 0.0002
460 ADVERSE REACTION 3 0.0002
461 LIVER DISORDER 10 0.0002
462 EAR INFECTION 6 0.0002
463 RHINITIS ALLERGIC 1 0.0002
464 SINUSITIS 23 0.0002
465 ACNE 17 0.0002
466 FACIAL PAIN 2 0.0002
467 MALIGNANT MELANOMA 3 0.0002
468 GASTROINTESTINAL INFECTION 2 0.0002
469 RASH 96 0.0002
470 BLOOD PRESSURE SYSTOLIC DECREASED 1 0.0002
471 HAEMOGLOBIN INCREASED 1 0.0002
472 SKIN LESION 6 0.0002
473 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 12 0.0002
474 DRY SKIN 29 0.0002
475 EYE OPERATION 1 0.0002
476 BLOOD CHOLESTEROL ABNORMAL 1 0.0002
477 INTERVERTEBRAL DISC DEGENERATION 2 0.0002
478 MEDICATION ERROR 12 0.0002
479 PAIN 131 0.0002
480 SKIN TIGHTNESS 1 0.0002
481 ASTHMA 24 0.0002
482 SARCOIDOSIS 1 0.0002
483 PRE-ECLAMPSIA 1 0.0002
484 LIP SWELLING 7 0.0002
485 ENDOMETRIOSIS 1 0.0002
486 RECTAL HAEMORRHAGE 9 0.0002
487 SUPRAVENTRICULAR TACHYCARDIA 2 0.0002
488 ALOPECIA 41 0.0002
489 IMPAIRED QUALITY OF LIFE 3 0.0002
490 DERMATITIS ATOPIC 11 0.0002
491 LIMB OPERATION 1 0.0002
492 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 10 0.0002
493 GUILLAIN-BARRE SYNDROME 1 0.0002
494 SKIN FISSURES 4 0.0002
495 THERAPY CHANGE 2 0.0002
496 DYSPEPSIA 20 0.0002
497 NASAL POLYPS 1 0.0002
498 SMALL FOR DATES BABY 1 0.0002
499 APPLICATION SITE SWELLING 1 0.0002
500 CORONARY ARTERY STENOSIS 1 0.0002
501 CORONARY ARTERIAL STENT INSERTION 1 0.0002
502 PATHOLOGICAL FRACTURE 1 0.0002
503 DRUG LEVEL DECREASED 2 0.0002
504 MUSCLE SPASMS 36 0.0002
505 PHLEBITIS 1 0.0002
506 PERIPHERAL VASCULAR DISORDER 1 0.0002
507 SKIN NECROSIS 1 0.0002
508 PERIORBITAL OEDEMA 1 0.0002
509 MALABSORPTION 1 0.0002
510 APLASTIC ANAEMIA 1 0.0002
511 BRAIN FOG 3 0.0002
512 WEIGHT FLUCTUATION 2 0.0002
513 APPLICATION SITE ERYTHEMA 5 0.0002
514 SENSITIVITY TO WEATHER CHANGE 1 0.0002
515 POLYARTHRITIS 1 0.0002
516 INCONTINENCE 2 0.0002
517 RESPIRATORY TRACT CONGESTION 3 0.0002
518 FOOD POISONING 1 0.0002
519 COMPRESSION FRACTURE 1 0.0002
520 HEREDITARY ANGIOEDEMA 2 0.0002
521 OVERWEIGHT 1 0.0002
522 PRODUCT SIZE ISSUE 1 0.0002
523 BEHAVIOUR DISORDER 1 0.0002
524 CHEILITIS 1 0.0002
525 ERYTHEMA OF EYELID 1 0.0002
526 RASH PRURITIC 10 0.0002
527 ADVERSE EVENT 17 0.0002
528 CONDITION AGGRAVATED 56 0.0002
529 HYDROCEPHALUS 1 0.0002
530 MUSCULOSKELETAL STIFFNESS 16 0.0002
531 NONSPECIFIC REACTION 1 0.0002
532 GASTROINTESTINAL PAIN 2 0.0002
533 DRY EYE 9 0.0002
534 BLOOD UREA INCREASED 3 0.0002
535 COLITIS ULCERATIVE 8 0.0002
536 OCULAR DISCOMFORT 2 0.0002
537 EYE INFECTION 2 0.0002
538 CHOLECYSTITIS ACUTE 1 0.0002
539 CHOLECYSTECTOMY 2 0.0002
540 EXERCISE TOLERANCE DECREASED 1 0.0002
541 SOCIAL AVOIDANT BEHAVIOUR 1 0.0002
542 BURNING SENSATION 12 0.0002
543 SURGERY 10 0.0002
544 VISUAL IMPAIRMENT 21 0.0002
545 BLOOD IRON DECREASED 2 0.0002
546 CHOLECYSTITIS 2 0.0002
547 HYPERLIPIDAEMIA 2 0.0002
548 SYMPTOM RECURRENCE 1 0.0002
549 COMPLICATION OF DEVICE REMOVAL 3 0.0002
550 SQUAMOUS CELL CARCINOMA OF SKIN 1 0.0002
551 DECREASED APPETITE 38 0.0002
552 MUSCLE SPASTICITY 2 0.0002
553 PIGMENTATION DISORDER 1 0.0002
554 PHARYNGITIS 2 0.0002
555 APPLICATION SITE IRRITATION 2 0.0002
556 PRE-EXISTING CONDITION IMPROVED 1 0.0002
557 SWOLLEN TONGUE 5 0.0002
558 POISONING 2 0.0002
559 INFUSION SITE SWELLING 1 0.0002
560 FLUID RETENTION 8 0.0002
561 EYE IRRITATION 9 0.0002
562 HEPATITIS 4 0.0002
563 EXPOSURE VIA SKIN CONTACT 4 0.0002
564 ANGINA UNSTABLE 1 0.0002
565 ORAL HERPES 3 0.0002
566 ECZEMA 8 0.0002
567 NEPHROLITHIASIS 7 0.0002
568 PRODUCT PREPARATION ISSUE 1 0.0002
569 NASOPHARYNGITIS 28 0.0002
570 DYSGRAPHIA 1 0.0002
571 PRODUCT FORMULATION ISSUE 1 0.0002
572 PANCREATITIS 8 0.0002
573 CHEST PAIN 28 0.0002
574 CARDIAC FAILURE ACUTE 1 0.0001
575 PREGNANCY 3 0.0001
576 SKIN MASS 1 0.0001
577 HAIR TEXTURE ABNORMAL 2 0.0001
578 CHOLECYSTITIS CHRONIC 1 0.0001
579 POST-TRAUMATIC STRESS DISORDER 1 0.0001
580 BREAST MASS 1 0.0001
581 EYE PRURITUS 5 0.0001
582 PRODUCT ADMINISTRATION ERROR 3 0.0001
583 COLITIS ISCHAEMIC 1 0.0001
584 METASTASES TO LYMPH NODES 1 0.0001
585 SINUS CONGESTION 2 0.0001
586 BLOOD TESTOSTERONE DECREASED 1 0.0001
587 CROHN'S DISEASE 1 0.0001
588 ONYCHOCLASIS 1 0.0001
589 RESPIRATION ABNORMAL 1 0.0001
590 ENCEPHALITIS 1 0.0001
591 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 26 0.0001
592 HYPOMAGNESAEMIA 2 0.0001
593 APPLICATION SITE REACTION 1 0.0001
594 SKIN REACTION 2 0.0001
595 BLINDNESS UNILATERAL 2 0.0001
596 DUODENAL ULCER 1 0.0001
597 SEASONAL ALLERGY 2 0.0001
598 PRODUCT DOSE OMISSION IN ERROR 4 0.0001
599 HAND FRACTURE 1 0.0001
600 THERAPY INTERRUPTED 10 0.0001
601 DERMATITIS BULLOUS 1 0.0001
602 FAECES SOFT 1 0.0001
603 LIQUID PRODUCT PHYSICAL ISSUE 1 0.0001
604 INTENTIONAL UNDERDOSE 1 0.0001
605 MAJOR DEPRESSION 1 0.0001
606 ORAL DISORDER 1 0.0001
607 ERYTHEMA 28 0.0001
608 OFF LABEL USE 118 0.0001
609 ARTHRALGIA 56 0.0001
610 FEELING DRUNK 1 0.0001
611 EYE SWELLING 5 0.0001
612 IMMUNODEFICIENCY 2 0.0001
613 SUNBURN 1 0.0001
614 ORAL PAIN 3 0.0001
615 HYPERTENSION 28 0.0001
616 INFECTION 19 0.0001
617 MATERNAL DRUGS AFFECTING FOETUS 1 0.0001
618 INTERCEPTED PRODUCT ADMINISTRATION ERROR 1 0.0001
619 PSORIASIS 17 0.0001
620 PRURITUS 50 0.0001
621 RENAL FAILURE CHRONIC 1 0.0001
622 HAEMOLYSIS 1 0.0001
623 APHTHOUS ULCER 1 0.0001
624 THERAPY PARTIAL RESPONDER 2 0.0001
625 ASTHENIA 48 0.0001
626 MULTIPLE ALLERGIES 1 0.0001
627 OCULAR HYPERAEMIA 6 0.0001
628 GINGIVAL PAIN 1 0.0001
629 ATRIAL FLUTTER 1 0.0001
630 ABORTION SPONTANEOUS 5 0.0001
631 LOCALISED INFECTION 3 0.0001
632 RHINITIS 1 0.0001
633 UNDERDOSE 9 0.0001
634 OEDEMA PERIPHERAL 15 0.0001
635 HICCUPS 1 0.0001
636 HYPERAESTHESIA 1 0.0001
637 HAIR DISORDER 1 0.0001
638 PHOTOSENSITIVITY REACTION 2 0.0001
639 SPINAL COMPRESSION FRACTURE 1 0.0001
640 SUICIDAL IDEATION 11 0.0001
641 DIZZINESS 59 0.0001
642 PNEUMONIA 38 0.0001
643 SCAR 2 0.0001
644 DRUG INEFFECTIVE 153 0.0001
645 ANXIETY 33 0.0001
646 MYOPATHY 1 0.0001
647 CARDIAC MURMUR 1 0.0001
648 PYELONEPHRITIS 1 0.0001
649 SKIN SWELLING 1 0.0001
650 ABDOMINAL DISTENSION 12 0.0001
651 VERTIGO 7 0.0001
652 RESPIRATORY SYNCYTIAL VIRUS INFECTION 1 0.0001
653 METASTASES TO LIVER 2 0.0001
654 PRODUCT COMMUNICATION ISSUE 1 0.0001
655 HYPERSENSITIVITY 21 0.0001
656 PURPURA 1 0.0001
657 PRODUCT DOSE OMISSION ISSUE 33 0.0001
658 PAIN OF SKIN 3 0.0001
659 HEAVY MENSTRUAL BLEEDING 1 0.0001
660 HIDRADENITIS 1 0.0001
661 INCREASED TENDENCY TO BRUISE 1 0.0001
662 UPPER RESPIRATORY TRACT INFECTION 5 0.0001
663 BREAST CANCER STAGE I 1 0.0001
664 CHEST DISCOMFORT 11 0.0001
665 FLANK PAIN 1 0.0001
666 PHOTOPHOBIA 2 0.0001
667 ABORTION INDUCED 1 0.0001
668 SPINAL DISORDER 1 0.0001
669 SPUTUM DISCOLOURED 1 0.0001
670 PAIN IN EXTREMITY 31 0.0001
671 DISEASE RECURRENCE 5 0.0001
672 SLEEP APNOEA SYNDROME 2 0.0001
673 GAIT DISTURBANCE 20 0.0001
674 AFFECT LABILITY 1 0.0001
675 DIARRHOEA 67 0.0001
676 ATELECTASIS 1 0.0001
677 BLOOD PRESSURE SYSTOLIC INCREASED 2 0.0001
678 PHARYNGEAL SWELLING 1 0.0001
679 ASCITES 3 0.0001
680 EMBEDDED DEVICE 1 0.0001
681 BLOOD PRESSURE ABNORMAL 2 0.0001
682 COMPLICATION OF DEVICE INSERTION 2 0.0001
683 HYPOTONIA 1 0.0001
684 SALIVARY HYPERSECRETION 1 0.0001
685 LACRIMATION INCREASED 3 0.0001
686 THERAPEUTIC RESPONSE DECREASED 6 0.0001
687 ABDOMINAL PAIN 23 0.0001
688 FEEDING DISORDER 2 0.0001
689 INSOMNIA 26 0.0001
690 INITIAL INSOMNIA 1 0.0001
691 EAR DISCOMFORT 1 0.0001
692 THERAPY CESSATION 5 0.0001
693 PRODUCT PREPARATION ERROR 2 0.0001
694 TEMPERATURE INTOLERANCE 1 0.0001
695 WEIGHT DECREASED 27 0.0001
696 POOR VENOUS ACCESS 1 0.0001
697 HYPERBILIRUBINAEMIA 1 0.0001
698 EYE DISCHARGE 1 0.0001
699 POLLAKIURIA 4 0.0001
700 PETECHIAE 1 0.0001
701 PYREXIA 33 0.0001
702 MOUTH ULCERATION 2 0.0001
703 CLOSTRIDIUM DIFFICILE COLITIS 1 0.0001
704 URINARY TRACT INFECTION 16 0.0001
705 BREAST PAIN 1 0.0001
706 BREAST CANCER METASTATIC 1 0.0001
707 RHINORRHOEA 6 0.0001
708 DISTURBANCE IN ATTENTION 5 0.0001
709 DECREASED ACTIVITY 1 0.0001
710 DEVICE DISLOCATION 4 0.0001
711 SKIN LACERATION 1 0.0001
712 PRODUCT DISPENSING ERROR 2 0.0001
713 PULMONARY THROMBOSIS 1 0.0001
714 OESOPHAGITIS 1 0.0001
715 TREATMENT NONCOMPLIANCE 5 0.0001
716 EXPIRED PRODUCT ADMINISTERED 3 0.0001
717 TOOTH DISORDER 2 0.0001
718 OBSTRUCTIVE AIRWAYS DISORDER 1 0.0001
719 SNEEZING 2 0.0001
720 SKIN INFECTION 1 0.0001
721 EYE PAIN 5 0.0001
722 REBOUND EFFECT 1 0.0001
723 APPLICATION SITE PRURITUS 2 0.0001
724 SCAB 1 0.0001
725 SKIN DISCOLOURATION 4 0.0001
726 PRODUCT SUBSTITUTION ISSUE 5 0.0001
727 FOETAL EXPOSURE DURING PREGNANCY 7 0.0001
728 CAESAREAN SECTION 1 0.0001
729 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 2 0.0001
730 HEART RATE DECREASED 3 0.0001
731 SEXUAL DYSFUNCTION 1 0.0001
732 NASAL CONGESTION 5 0.0001
733 LYMPHADENOPATHY 3 0.0001
734 BACTERAEMIA 1 0.0001
735 RASH ERYTHEMATOUS 4 0.0001
736 NOCTURIA 1 0.0001
737 PANIC ATTACK 3 0.0001
738 ACCIDENTAL OVERDOSE 3 0.0001
739 INJECTION SITE URTICARIA 2 0.0001
740 GLOMERULAR FILTRATION RATE DECREASED 1 0.0001
741 SMALL INTESTINAL OBSTRUCTION 1 0.0001
742 TENDON RUPTURE 1 0.0001
743 CYST 1 0.0001
744 HAIR COLOUR CHANGES 1 0.0001
745 AGEUSIA 2 0.0001
746 INJECTION SITE DISCOLOURATION 1 0.0001
747 LEUKOPENIA 4 0.0001
748 HOT FLUSH 6 0.0001
749 DERMATITIS ALLERGIC 1 0.0001
750 TACHYCARDIA 7 0.0001
751 INJECTION SITE IRRITATION 1 0.0001
752 DEVICE DEPLOYMENT ISSUE 1 0.0001
753 HYPOPHAGIA 2 0.0001
754 ROTATOR CUFF SYNDROME 1 0.0001
755 DRUG RESISTANCE 2 0.0001
756 METASTASES TO CENTRAL NERVOUS SYSTEM 1 0.0001
757 PLATELET COUNT INCREASED 1 0.0001
758 GASTRITIS 2 0.0001
759 IMMUNE SYSTEM DISORDER 1 0.0001
760 PULMONARY CONGESTION 1 0.0001
761 DEPRESSED LEVEL OF CONSCIOUSNESS 3 0.0001
762 SARS-COV-2 TEST POSITIVE 1 0.0001
763 THROAT TIGHTNESS 2 0.0001
764 IMPAIRED GASTRIC EMPTYING 1 0.0001
765 MALAISE 32 0.0001
766 APPLICATION SITE RASH 1 0.0001
767 INJECTION SITE REACTION 5 0.0001
768 ABNORMAL DREAMS 2 0.0001
769 ORAL DISCOMFORT 1 0.0001
770 FEELING COLD 2 0.0001
771 HUNGER 1 0.0001
772 MASS 1 0.0001
773 HEART RATE INCREASED 7 0.0001
774 FLATULENCE 4 0.0001
775 BRONCHOSPASM 1 0.0001
776 ANGINA PECTORIS 2 0.0001
777 BALANCE DISORDER 6 0.0001
778 PARAESTHESIA ORAL 1 0.0001
779 ANOSMIA 1 0.0001
780 DYSPNOEA 39 0.0001
781 COMPLICATION ASSOCIATED WITH DEVICE 1 0.0001
782 INTENTIONAL PRODUCT MISUSE 6 0.0001
783 COVID-19 12 0.0001
784 ANGIOEDEMA 3 0.0001
785 URINARY INCONTINENCE 2 0.0001
786 SKIN HAEMORRHAGE 1 0.0001
787 BONE LOSS 1 0.0001
788 HALLUCINATION 5 0.0001
789 CORONARY ARTERY DISEASE 2 0.0001
790 BLOOD COUNT ABNORMAL 1 0.0001
791 OSTEOPENIA 1 0.0001
792 VISION BLURRED 9 0.0001
793 BLOOD PRESSURE INCREASED 10 0.0001
794 HEADACHE 41 0.0001
795 TINNITUS 3 0.0001
796 HYPOKALAEMIA 3 0.0001
797 DELUSION 1 0.0001
798 ACUTE MYELOID LEUKAEMIA 1 0.0001
799 MENINGIOMA 1 0.0001
800 ARRHYTHMIA 3 0.0001
801 DYSPHAGIA 6 0.0001
802 MOOD SWINGS 2 0.0001
803 HIP FRACTURE 2 0.0001
804 FATIGUE 48 0.0001
805 BLOOD POTASSIUM INCREASED 1 0.0001
806 METASTASES TO BONE 1 0.0001
807 EYE DISORDER 2 0.0001
808 BACK PAIN 14 0.0001
809 PSYCHOMOTOR HYPERACTIVITY 1 0.0001
810 FUNGAL INFECTION 2 0.0001
811 SKIN DISORDER 2 0.0001
812 CONSTIPATION 13 0.0001
813 NAUSEA 47 0.0001
814 FACE OEDEMA 1 0.0001
815 CANDIDA INFECTION 1 0.0001
816 GASTRIC DISORDER 2 0.0001
817 ILLNESS 6 0.0001
818 MUSCULOSKELETAL DISCOMFORT 1 0.0001
819 NEOPLASM PROGRESSION 2 0.0001
820 ORTHOSTATIC HYPOTENSION 1 0.0001
821 RASH MACULAR 2 0.0001
822 DEVICE USE ISSUE 1 0.0001
823 LYMPHOCYTE COUNT DECREASED 1 0.0001
824 HEAD DISCOMFORT 1 0.0001
825 ISCHAEMIC STROKE 1 0.0001
826 GALLBLADDER DISORDER 1 0.0001
827 GOUT 1 0.0001
828 INJECTION SITE PAIN 17 0.0001
829 GASTROENTERITIS VIRAL 1 0.0001
830 LEUKOCYTOSIS 1 0.0001
831 RESTLESS LEGS SYNDROME 1 0.0001
832 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 1 0.0001
833 DYSURIA 2 0.0001
834 ANAPHYLACTIC REACTION 3 0.0001
835 BRONCHITIS 4 0.0001
836 CONJUNCTIVITIS 1 0.0001
837 DYSGEUSIA 4 0.0001
838 BACTERIAL INFECTION 1 0.0001
839 HYPONATRAEMIA 3 0.0001
840 DYSPNOEA EXERTIONAL 2 0.0001
841 BLOOD SODIUM DECREASED 1 0.0001
842 BLOOD URINE PRESENT 1 0.0001
843 NEUROPATHY PERIPHERAL 5 0.0001
844 MUSCULOSKELETAL DISORDER 1 0.0001
845 FEELING JITTERY 1 0.0001
846 ANAEMIA 10 0.0001
847 POST PROCEDURAL COMPLICATION 1 0.0001
848 HOSPITALISATION 8 0.0001
849 DYSTONIA 1 0.0001
850 DYSPHONIA 3 0.0001
851 CHOKING 1 0.0001
852 PALPITATIONS 6 0.0001
853 BONE PAIN 3 0.0001
854 ARTHRITIS 4 0.0001
855 CYTOKINE RELEASE SYNDROME 1 0.0000
856 THROMBOSIS 4 0.0000
857 DYSKINESIA 2 0.0000
858 FLUSHING 5 0.0000
859 INJURY ASSOCIATED WITH DEVICE 1 0.0000
860 RIB FRACTURE 1 0.0000
861 ACCIDENTAL EXPOSURE TO PRODUCT 5 0.0000
862 INJECTION SITE ERYTHEMA 6 0.0000
863 TREMOR 8 0.0000
864 RHABDOMYOLYSIS 2 0.0000
865 DERMATITIS 1 0.0000
866 SKIN EXFOLIATION 4 0.0000
867 EATING DISORDER 1 0.0000
868 IMPAIRED WORK ABILITY 1 0.0000
869 WHITE BLOOD CELL COUNT DECREASED 5 0.0000
870 BLOOD CREATININE INCREASED 3 0.0000
871 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
872 INTERVERTEBRAL DISC PROTRUSION 1 0.0000
873 MELAENA 1 0.0000
874 BLOOD PRESSURE DECREASED 3 0.0000
875 STEVENS-JOHNSON SYNDROME 1 0.0000
876 RASH MACULO-PAPULAR 1 0.0000
877 THERAPEUTIC RESPONSE UNEXPECTED 2 0.0000
878 CHROMATURIA 1 0.0000
879 PRODUCT AVAILABILITY ISSUE 1 0.0000
880 MUSCLE TWITCHING 1 0.0000
881 OROPHARYNGEAL PAIN 4 0.0000
882 COUGH 12 0.0000
883 DISEASE PROGRESSION 5 0.0000
884 PRODUCT PRESCRIBING ERROR 1 0.0000
885 MENTAL IMPAIRMENT 1 0.0000
886 NEURALGIA 1 0.0000
887 EPISTAXIS 3 0.0000
888 SYNCOPE 4 0.0000
889 CELLULITIS 2 0.0000
890 HAEMATEMESIS 1 0.0000
891 INJECTION SITE SWELLING 3 0.0000
892 ERECTILE DYSFUNCTION 1 0.0000
893 SKIN ULCER 1 0.0000
894 DIPLOPIA 1 0.0000
895 RESPIRATORY TRACT INFECTION 1 0.0000
896 NERVOUSNESS 2 0.0000
897 SEDATION 1 0.0000
898 SPEECH DISORDER 2 0.0000
899 ANHEDONIA 1 0.0000
900 ASPARTATE AMINOTRANSFERASE INCREASED 2 0.0000
901 INJECTION SITE BRUISING 3 0.0000
902 BREAST CANCER FEMALE 1 0.0000
903 BLOOD BILIRUBIN INCREASED 1 0.0000
904 LIMB INJURY 1 0.0000
905 PALLOR 1 0.0000
906 MOOD ALTERED 1 0.0000
907 HAEMATOCHEZIA 2 0.0000
908 INFLUENZA 4 0.0000
909 MYALGIA 6 0.0000
910 INTENTIONAL DOSE OMISSION 1 0.0000
911 INTERNATIONAL NORMALISED RATIO INCREASED 1 0.0000
912 RED BLOOD CELL COUNT DECREASED 1 0.0000
913 HERPES ZOSTER 2 0.0000
914 NEEDLE ISSUE 1 0.0000
915 PRODUCT STORAGE ERROR 3 0.0000
916 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
917 PREMATURE BABY 1 0.0000
918 HEPATIC FAILURE 1 0.0000
919 PLEURAL EFFUSION 2 0.0000
920 INJECTION SITE RASH 1 0.0000
921 ALANINE AMINOTRANSFERASE INCREASED 2 0.0000
922 FEMUR FRACTURE 1 0.0000
923 NERVOUS SYSTEM DISORDER 1 0.0000
924 BONE DENSITY DECREASED 1 0.0000
925 HYPOTHYROIDISM 1 0.0000
926 LOSS OF CONSCIOUSNESS 4 0.0000
927 HYPERHIDROSIS 4 0.0000
928 ATRIAL FIBRILLATION 3 0.0000
929 PRODUCT DOSE OMISSION 2 0.0000
930 CHOLELITHIASIS 1 0.0000
931 OSTEONECROSIS 1 0.0000
932 FALL 10 0.0000
933 NEOPLASM MALIGNANT 2 0.0000
934 SOMNOLENCE 6 0.0000
935 HAEMATURIA 1 0.0000
936 NIGHTMARE 1 0.0000
937 RESTLESSNESS 1 0.0000
938 INTESTINAL OBSTRUCTION 1 0.0000
939 COLITIS 1 0.0000
940 CHRONIC KIDNEY DISEASE 2 0.0000
941 SEIZURE 3 0.0000
942 FEELING ABNORMAL 6 0.0000
943 PROSTATE CANCER 2 0.0000
944 DEVICE BREAKAGE 1 0.0000
945 NEUTROPHIL COUNT DECREASED 1 0.0000
946 INFLUENZA LIKE ILLNESS 2 0.0000
947 HYPOACUSIS 1 0.0000
948 MENTAL DISORDER 1 0.0000
949 DEHYDRATION 3 0.0000
950 NO ADVERSE EVENT 4 0.0000
951 NEUTROPENIA 3 0.0000
952 BREAST CANCER 2 0.0000
953 COGNITIVE DISORDER 1 0.0000
954 PULMONARY EMBOLISM 2 0.0000
955 MULTIPLE SCLEROSIS 1 0.0000
956 BLOOD GLUCOSE DECREASED 1 0.0000
957 AGGRESSION 1 0.0000
958 MALIGNANT NEOPLASM PROGRESSION 2 0.0000
959 DEPRESSED MOOD 1 0.0000
960 BRADYCARDIA 1 0.0000
961 PLATELET COUNT DECREASED 2 0.0000
962 OVERDOSE 4 0.0000
963 THROMBOCYTOPENIA 2 0.0000
964 CONVULSION 1 0.0000
965 LETHARGY 1 0.0000
966 EMOTIONAL DISTRESS 2 0.0000
967 DEEP VEIN THROMBOSIS 1 0.0000
968 RENAL FAILURE 2 0.0000
969 INJECTION SITE PRURITUS 1 0.0000
970 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 3 0.0000
971 INCORRECT DOSE ADMINISTERED 3 0.0000
972 DRUG INTERACTION 2 0.0000
973 INJECTION SITE HAEMORRHAGE 1 0.0000
974 COMPLETED SUICIDE 1 0.0000
975 RENAL IMPAIRMENT 1 0.0000
976 CEREBROVASCULAR ACCIDENT 2 0.0000
977 MYOCARDIAL INFARCTION 2 0.0000
978 BLOOD GLUCOSE INCREASED 2 0.0000
979 HYPOTENSION 2 0.0000
980 HAEMOGLOBIN DECREASED 1 0.0000
981 HAEMORRHAGE 1 0.0000
982 SEPSIS 1 0.0000
983 CHILLS 1 0.0000
984 DEATH 7 0.0000
985 ACUTE KIDNEY INJURY 1 0.0000
986 DRUG DEPENDENCE 1 0.0000
987 DRUG DOSE OMISSION 1 0.0000